Newedge, a global leader in multi-asset brokerage and clearing, announced the appointment of Mark Gonzalez as Head of OTC Clearing Sales Americas. Gonzalez will be based in New York and report to Adam Cohen, head of institutional clearing sales, Americas, prime clearing services.

“Mandatory clearing of OTC interest rate swaps offers significant growth opportunities which we successfully tapped into over past year,” said Adam Cohen, Head of Institutional Clearing Sales Americas, Prime Clearing Services at Newedge. “Hiring Mark represents a statement of intent. His outstanding expertise and market knowledge will help us further enhance our offering to meet the specific needs of our clients in the US, Canada and Latin America.”

“I am delighted to join Newedge at these times of change in derivatives clearing. As the world’s largest clearer of listed derivatives, the company is in an unprecedented position to help clients navigate the evolving choice of products and clearing venues and access cross margining opportunities,” commented Mark Gonzalez on his appointment.

Mark joins from BNY Mellon Clearing where he was Global Chief Operating Officer (COO) and Head of Sales providing services in the listed and OTC derivatives market to institutional clients. Mark has more than 16 years’ experience in senior operational and marketing roles within global clearing and trading organizations. Prior to BNY Mellon, he served as an advisor to Ardmore Park Capital and was a founding partner and COO for Capstone Holdings Group.

Mark holds a B.A. from the University of Connecticut.

Newedge’s OTC clearing services, part of a multi-asset class offering designed for investment firms of all sizes, is supported by a partnership with Societe Generale Corporate & Investment Banking (SG CIB).

Newedge is a leader in global exchange-traded and cleared derivatives and amongst the top clearing firms in derivatives trading worldwide, ranking third in the USA as measured by customer assets.